← Open Payments lookup

ARACHCHIGE MUTHUKUDA: Open Payments

NPI 1073770616 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$531 in 18 payments from 8 companies in 2025. Trend: 2023 $32 · 2024 $22 · 2025 $531

Food & beverage: $431Education: $100
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.4$126
Teva Pharmaceuticals USA, Inc.2$120
Vanda Pharmaceuticals Inc.2$74
E.R. Squibb & Sons, L.L.C.4$65
Axsome Therapeutics, Inc.2$54
Lundbeck LLC2$37
Janssen Pharmaceuticals, Inc1$30
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$25

Products named: INGREZZA, FANAPT, COBENFY, Auvelity, INVEGA SUSTENNA, CAPLYTA, UZEDY, ABILIFY ASIMTUFII.

Industry payments across MD — which companies pay providers there.